| Mary Kathryn Kramer, APRN, CNM | |
|
1401 Madison Ave, Covington, KY 41011-3313 | |
| (859) 655-6100 | |
| Not Available |
| Full Name | Mary Kathryn Kramer |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 24 Years |
| Location | 1401 Madison Ave, Covington, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841283611 | NPI | - | NPPES |
| 78005535 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 3003379 (Kentucky) | Primary |
| 363L00000X | Nurse Practitioner | 3003379 (Kentucky) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthpoint Family Care, Inc. | 9638089642 | 52 |
News Archive
The method is based on a mathematical model that determines when a cancer becomes drug-resistant during therapy. It does this by estimating the probability of finding drug-resistant mutant cells at different stages of cancer progression and examining the fate of individual mutant colonies during therapy.
GenMark Diagnostics, Inc. today reported additional financial information for the fourth quarter ended December 31, 2011 that was unavailable at the time it released preliminary financial results on March 8, 2012.
According to the latest research breast cancer studies funded by drug companies are more likely to come up with positive findings than those without pharmaceutical industry backing.
Beating back Covid right now comes down to balancing supply and demand.
› Verified 1 days ago
| Entity Name | Summit Medical Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881026169 PECOS PAC ID: 2163326240 Enrollment ID: O20031120000738 |
News Archive
The method is based on a mathematical model that determines when a cancer becomes drug-resistant during therapy. It does this by estimating the probability of finding drug-resistant mutant cells at different stages of cancer progression and examining the fate of individual mutant colonies during therapy.
GenMark Diagnostics, Inc. today reported additional financial information for the fourth quarter ended December 31, 2011 that was unavailable at the time it released preliminary financial results on March 8, 2012.
According to the latest research breast cancer studies funded by drug companies are more likely to come up with positive findings than those without pharmaceutical industry backing.
Beating back Covid right now comes down to balancing supply and demand.
› Verified 1 days ago
| Entity Name | St Elizabeth Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932187937 PECOS PAC ID: 0648174623 Enrollment ID: O20031121000206 |
News Archive
The method is based on a mathematical model that determines when a cancer becomes drug-resistant during therapy. It does this by estimating the probability of finding drug-resistant mutant cells at different stages of cancer progression and examining the fate of individual mutant colonies during therapy.
GenMark Diagnostics, Inc. today reported additional financial information for the fourth quarter ended December 31, 2011 that was unavailable at the time it released preliminary financial results on March 8, 2012.
According to the latest research breast cancer studies funded by drug companies are more likely to come up with positive findings than those without pharmaceutical industry backing.
Beating back Covid right now comes down to balancing supply and demand.
› Verified 1 days ago
| Entity Name | Healthpoint Family Care, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508889742 PECOS PAC ID: 9638089642 Enrollment ID: O20040708000655 |
News Archive
The method is based on a mathematical model that determines when a cancer becomes drug-resistant during therapy. It does this by estimating the probability of finding drug-resistant mutant cells at different stages of cancer progression and examining the fate of individual mutant colonies during therapy.
GenMark Diagnostics, Inc. today reported additional financial information for the fourth quarter ended December 31, 2011 that was unavailable at the time it released preliminary financial results on March 8, 2012.
According to the latest research breast cancer studies funded by drug companies are more likely to come up with positive findings than those without pharmaceutical industry backing.
Beating back Covid right now comes down to balancing supply and demand.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Kathryn Kramer, APRN, CNM 215 E 11th St, Newport, KY 41071-2203 Ph: (859) 655-6100 | Mary Kathryn Kramer, APRN, CNM 1401 Madison Ave, Covington, KY 41011-3313 Ph: (859) 655-6100 |
News Archive
The method is based on a mathematical model that determines when a cancer becomes drug-resistant during therapy. It does this by estimating the probability of finding drug-resistant mutant cells at different stages of cancer progression and examining the fate of individual mutant colonies during therapy.
GenMark Diagnostics, Inc. today reported additional financial information for the fourth quarter ended December 31, 2011 that was unavailable at the time it released preliminary financial results on March 8, 2012.
According to the latest research breast cancer studies funded by drug companies are more likely to come up with positive findings than those without pharmaceutical industry backing.
Beating back Covid right now comes down to balancing supply and demand.
› Verified 1 days ago
Amanda Marie Dalhover, APRN, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1401 Madison Ave, Covington, KY 41011 Phone: 859-655-6211 |